World Drug Safety Congress Americas

We are so excited to give you a sneak peek look into what to expect at the World Drug Safety Congress Americas 2025 – plus hear from key #PV leaders on why we are the go-to event for the drug safety community! ?? ??? Watch our video here for all the details ? https://lnkd.in/edsdxgFa ?????? ?????????? ??????... ? Our largest attendance of pharma and biotech powerhouses ? Cutting-edge insights from the key stakeholders shaping the future of #pharmacovigilance ? Networking opportunities with industry experts ? Innovative technologies and innovations transforming the drug safety space ? Case studies and real-world applications ? Regulatory updates and compliance strategies for navigating evolving safety standards across different regions ??? ... AND MORE. Don't miss out – secure your spot at the event shaping the future of?#drugsafety?today! ?????? ???????? ???????????? ?????????? ? ?? Pharma, biotechs, hospitals & academia book for ????????! Limited complimentary VIP passes available for the first who apply here:?https://lnkd.in/gcNNXRT3 ?? Discounted group rates available for a limited time – register your team and save up to ????% today:?https://lnkd.in/gSanq3SV #WorldDrugSafety ??? November 4-6 ?? Boston Convention & Exhibition Center

Our Gold Sponsors are sending their best to the World Drug Safety Congress Americas 2025! ?? Check out the latest confirmed to take the stage this fall in Boston to showcase their?#PV?expertise, latest innovations, and new technologies shaping the future of?#drugsafety?? ??Kevin Fetterman, Executive Director,?Orbit by Feith Systems ? AMIT JAIN, Founder, Ultragenic Research and Technologies ? Dr. Jay Dave, Technical Director, Global Pharmacovigilance & Risk Management, COD Research ? Asad Rashid, Vice President Safety and PV, Syneos Health ? Howard Abroms, Vice President, Global Business Development, Soterius, Inc. ? Jonathon Romero, PhD, AI and Machine Learning Specialist, Syneos Health Don't miss out – register below to join them and hundreds of #drugsafety stakeholders who have already secured their ticket: ?? Pharma, biotechs, hospitals & academia book for ????????! Limited complimentary VIP passes available for the first who apply here:?https://lnkd.in/gcNNXRT3 ?? Discounted group rates available – register your team and save up to ????% today:?https://lnkd.in/gSanq3SV ???????????????????? ???? ?????????????? ????????????????? ?? Download our 2025 brochure to browse all opportunities today ? https://lnkd.in/g4H4V63z ?? Inquire ??https://lnkd.in/gsnPajnr #WorldDrugSafety ??? November 4-6 ?? Boston Convention & Exhibition Center

Today, we recognize?National Adverse Drug Event (ADE) Awareness Day, a crucial day to spotlight the impact of medication-related harm and the importance of drug safety. ???? ADEs are the third leading cause of death in the United States – causing nearly?1.3 million emergency room visits?and?350,000 hospitalizations?annually. Studies report nearly 50% ADEs are?preventable?with the right monitoring, reporting, and education. At the?World Drug Safety Congress Americas, we are committed to driving conversations and solutions that?enhance #pharmacovigilance, improve reporting systems, and ensure #patientsafety?at every stage of the drug lifecycle. By coming together as an industry, we can?mitigate risks, empower healthcare professionals, and protect patients worldwide from ADEs. ?????? Join us at #WorldDrugSafety 2025 to drive meaningful change – register below! ? ?? Pharma, biotechs, hospitals & academia book for ????????! Limited complimentary VIP passes available for the first who apply here: https://lnkd.in/gcNNXRT3 ?? Discounted group rates available – register your team and save up to ????% today: https://lnkd.in/gSanq3SV American Society of Pharmacovigilance #NationalADEAwarenessDay?#DrugSafety #ADEAwareness #PatientSafety #FourthCause #ADE

?? We are excited to introduce the World Drug Safety Congress Americas' 2025?Silver Sponsor – Quartica, Inc.?? Quartica’s MARS Platform is the leading AI solution for #pharmacovigilance departments, covering every aspect of generating, managing, and planning #PV activities for everything outside of ICSR processing. Unlike other solutions which focus on individual areas of a PV Department, MARS takes a holistic, platform approach to support and force multiply entire teams (and ROI). From automated workflows to intuitive reporting tools, MARS simplifies complex processes while maintaining the highest level of compliance, empowering PV teams to focus on what matters most—#patientsafety and operational excellence. ?? ?? ?????????? ????????: https://lnkd.in/eKyKBJUa ?????????????? ???? ???????? ???????? ???????????? ?????????????? ?????? ????????????????????????? ?? Register your team and save with?our new?group rates today – ?https://lnkd.in/gSanq3SV + ?????????????? ?????????????????????????? ?????? ???????????? for pharma & biotech affiliated SMEs, academia, and hospital reps are available here – https://lnkd.in/gcNNXRT3 ?????????????? ???? ???????????????? ???????? ??????????????'?? ???????? ?????? ???????? ???????? ???????? ??????????????? ?? Inquire to exhibit at the Americas most important #drugsafety event today – https://lnkd.in/gsnPajnr *?????????????? ???????????? ?????????? ??????????????????? ???????? ???? ?????????? ???????? ?????????? ?????????????????????????? ???? ?????? ???????????????? ???? ???????? ????????'?? ??????????? ???Download our 2025 brochure – https://lnkd.in/g4H4V63z #WorldDrugSafety ??? November 4-6 ?? Boston Convention & Exhibition enter

New report on Real-World Data and Real-World Evidence in Regulatory Decision Making: Report Summary From the Council for International Organizations of Medical Sciences (CIOMS) Working Group XIII Thank you for sharing Juhaeri Juhaeri and looking forward to having you speak on advances in safety signal detection using real-world data at the World Drug Safety Congress Americas !

That time I spoke at World Drug Safety Americas - packed room with eager individuals! stay smart folks! World Drug Safety Congress Americas #pharmacovigilance

New expert speakers continue to roll in for the World Drug Safety Congress Americas 2025, and we're thrilled to highlight this week's latest additions ? ?? Oleg Zvenigorodsky, PharmD, Director, Medical Safety / Innovation Lead, Jazz Pharmaceuticals ?? Ankita Srivastava, Head of Pharmacovigilance, Vistagen ?? Walter Straus, M.D., Vice President, Clinical Safety & Risk Management, Moderna Join hundreds of drug safety leaders for cutting-edge discussions on AI in PV, risk-benefit assessment, the future of #patientsafety, and beyond. ???? Get your ticket to the premier event for #pharmacovigilance and #drugsafety professionals below ?? ??????????????????????? ?????????? ???????????– Bring your team and save up to 25% on tickets when you register here: https://lnkd.in/gSanq3SV ????????????????? ???????? ?????? ???????????? ???????????????????– Exclusive to pharma & biotech affiliated SMEs, academia, and hospital reps only. Secure yours now before they're gone: https://lnkd.in/gcNNXRT3 ???????????????????? ???? ?????????????? ?????? ??????-???????? ?????????????? ????????????? ??? Inquire below or contact Kaylee Nguyen at [email protected] to get the conversation started today! https://lnkd.in/gsnPajnr #WorldDrugSafety November 4-6 Boston Convention & Exhibition Center

Patient safety is at the heart of everything we do. ?? ?? As we recognize?Patient Safety Awareness Week?(PSAW), we are proud to reaffirm our commitment to driving innovation, collaboration, and best practices in drug safety. At the World Drug Safety Congress Americas 2025, we're bringing together global leaders and industry experts to shape the future of #pharmacovigilance, risk management, regulatory compliance, and beyond – because every decision made in the #drugsafety space has an impact on the lives of patients. Catch expert insights from our all-star speakers dedicated to #patientsafety, including ? ☆ Victoria Bartasek, Senior Associate Director, Patient Safety and Pharmacovigilance - US Operations,?Boehringer Ingelheim ☆ Mariette Boerstoel-Streefland, Senior Vice President, Worldwide Patient Safety Officer,?Bristol Myers Squibb ☆ Gloria Bustos Busto, PhD, Global Head Global Patient Safety,?Vantive ☆ Nancy Dubois, Senior Director, Head of Global Patient Safety, US Region,?EMD Serono, Inc. ☆ Samad Jahendideh, Director, Patient Safety,?AstraZeneca ☆ Gerson Peltz MD, MPH, Senior Vice President of Patient Safety & Pharmacovigilance,?Arcus Biosciences ☆ Pav Rishiraj, Director, Head of Patient Safety,?Ipsen?& PV Expert Chair,?The Association of the British Pharmaceutical Industry (ABPI) ☆ Dr Milind Sardesai MBBS, MHSc, Senior Director, Safety Surveillance, Global Patient Safety,?Novo Nordisk ☆ Katie Ellis Tupe, Senior Manager, US Patient Safety Operations,?EMD Serono, Inc. ??? Join them and be a part of this critical conversation – get?????% ????????????????????? for the next 48 hours in recognition of PSAW. Book below with code??????????????by this Friday, March 14, and get your $2,995 ticket below for just $900?? https://lnkd.in/gSanq3SV Plus, we have a ?????????????? ???????????? ??????????????????????????????? ?????? ??????????????????????????????? for pharma & biotech affiliated SMEs, academia, and hospital reps. Secure your VIP pass here: https://lnkd.in/gcNNXRT3 Let's advance patient safety, together. ???? #WorldDrugSafety #PatientSafetyAwarenessWeek #PSAW Center for Patient Safety

In just under 8 months, the most important drug safety event in the Americas is coming to Boston! ?? ?????? ???????????? ?????? ?????????? ???????? ???????????? ???????????????? ???????????????? ????????? ? Discover the latest research & technologies on our packed expo floor ? Meet with the largest gathering of pharma & biotech powerhouses ? Keynotes from top industry experts ? Featured presentations across 7 track stages ? Engage in interactive panels, roundtable discussions & 1-to-1 meetings ? Develop you professional network & find your next partner and MORE. ??????'?? ?????????????? ?????????????????? ?????????? ????????????????????? Roche, Denovo Biopharma,?Boehringer Ingelheim, Sanofi, Health Canada | Santé Canada, UBC,?Bristol Myers Squibb, Biogen, Jazz Pharmaceuticals, Amgen, Bayer, Moderna, Novo Nordisk,?Takeda, Amneal Pharmaceuticals, Johnson & Johnson, IQVIA, Pfizer, AstraZeneca, PharSafer Associates Ltd, BeiGene, AbbVie,?and so many more! ? Secure your spot today ? ???????????????? ???????? ???????? & ???????? ???????? ?????? ???????????????????? ?????????? ?????????? ??? https://lnkd.in/gSanq3SV ?????????????? ?????????????????????????? ?????? ???????????? ?????????????????? ?????? ???????????? & ?????????????? ???????????????????? ????????, ????????????????, & ???????????????? ???????? ????https://lnkd.in/gcNNXRT3 #WorldDrugSafety ??? November 4-6 ?? Boston Convention & Exhibition Center

#drugsafety update of the day: Check this real-world #pharmacovigilance study of omalizumab using disproportionality analysis in the FDA #adversedrugevents reporting system database The findings of the article highlight the importance of continuous #postmarketingsurveillance to monitor and evaluate the safety profile of omalizumab in #real-world clinical setting World Drug Safety Congress Americas